DEXMETHYLPHENIDATE (is an active metabolite) | DEXMETHYLPHENIDATE METHYLPHENIDATE | ATC N06BA04
NERVOUS SYSTEM CNS STIMULANT ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DOPAMINE REUPTAKE INHIBITORS NOREPINEPHRINE REUPTAKE INHIBITOR NERVOUS SYSTEM | ORAL TRANSDERMAL | Cmax 73 NANOMOLAR (20 MILLIGRAM) Tmax 6.8 HOUR F 23.5 PERCENT VD 169 LITER (65 KILOGRAM) PPB 15 PERCENT Cl 33 LITER / HOUR HT 3.2 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | SODIUM-DEPENDENT NORADRENALINE TRANSPORTER SODIUM-DEPENDENT DOPAMINE TRANSPORTER SODIUM-DEPENDENT SEROTONIN TRANSPORTER | Sodium-dependent noradrenaline transporter UNIPROT P23975 SLC6A2 -- Sodium-dependent dopamine transporter UNIPROT Q01959 SLC6A3 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
SERDEXMETHYLPHENIDATE (has an active metabolite) | SERDEXMETHYLPHENIDATE | ATC N06BA15
NERVOUS SYSTEM PRODRUG OF DEXMETHYLPHENIDATE CENTRAL NERVOUS SYSTEM STIMULANT TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) BLOCKS THE REUPTAKE OF NOREPINEPHRINE AND DOPAMINE | ORAL | Tmax 2 HOUR F 3 PERCENT VD 1904.5 LITER (65 KILOGRAM) PPB 56 PERCENT Cl 234 LITER / HOUR HT 5.7 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | SODIUM-DEPENDENT NORADRENALINE TRANSPORTER SODIUM-DEPENDENT DOPAMINE TRANSPORTER SODIUM-DEPENDENT SEROTONIN TRANSPORTER | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |